212 related articles for article (PubMed ID: 31343460)
1. Combination of a δ-opioid Receptor Agonist and Loperamide Produces Peripherally-mediated Analgesic Synergy in Mice.
Bruce DJ; Peterson CD; Kitto KF; Akgün E; Lazzaroni S; Portoghese PS; Fairbanks CA; Wilcox GL
Anesthesiology; 2019 Sep; 131(3):649-663. PubMed ID: 31343460
[TBL] [Abstract][Full Text] [Related]
2. Topical Application of Loperamide/Oxymorphindole, Mu and Delta Opioid Receptor Agonists, Reduces Sensitization of C-fiber Nociceptors that Possess Na
Uhelski ML; Bruce D; Speltz R; Wilcox GL; Simone DA
Neuroscience; 2020 Oct; 446():102-112. PubMed ID: 32858141
[TBL] [Abstract][Full Text] [Related]
3. Ligand requirements for involvement of PKCε in synergistic analgesic interactions between spinal μ and δ opioid receptors.
Schuster DJ; Metcalf MD; Kitto KF; Messing RO; Fairbanks CA; Wilcox GL
Br J Pharmacol; 2015 Jan; 172(2):642-53. PubMed ID: 24827408
[TBL] [Abstract][Full Text] [Related]
4. Development of an effective topical liposomal formulation for localized analgesia and anti-inflammatory actions in the Complete Freund's Adjuvant rodent model of acute inflammatory pain.
Iwaszkiewicz KS; Hua S
Pain Physician; 2014; 17(6):E719-35. PubMed ID: 25415787
[TBL] [Abstract][Full Text] [Related]
5. Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity.
DeHaven-Hudkins DL; Burgos LC; Cassel JA; Daubert JD; DeHaven RN; Mansson E; Nagasaka H; Yu G; Yaksh T
J Pharmacol Exp Ther; 1999 Apr; 289(1):494-502. PubMed ID: 10087042
[TBL] [Abstract][Full Text] [Related]
6. Antihyperalgesic effects of loperamide in a model of rat neuropathic pain are mediated by peripheral delta-opioid receptors.
Shinoda K; Hruby VJ; Porreca F
Neurosci Lett; 2007 Jan; 411(2):143-6. PubMed ID: 17110034
[TBL] [Abstract][Full Text] [Related]
7. Peripheral antinociceptive effects of mu- and delta-opioid receptor agonists in NOS2 and NOS1 knockout mice during chronic inflammatory pain.
Leánez S; Hervera A; Pol O
Eur J Pharmacol; 2009 Jan; 602(1):41-9. PubMed ID: 19041302
[TBL] [Abstract][Full Text] [Related]
8. Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition.
Hua S; Cabot PJ
Pain Physician; 2013; 16(3):E199-216. PubMed ID: 23703419
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist--loperamide.
Nozaki-Taguchi N; Yaksh TL
Anesthesiology; 1999 Jan; 90(1):225-34. PubMed ID: 9915332
[TBL] [Abstract][Full Text] [Related]
10. Tolerance develops to the antiallodynic effects of the peripherally acting opioid loperamide hydrochloride in nerve-injured rats.
He SQ; Yang F; Perez FM; Xu Q; Shechter R; Cheong YK; Carteret AF; Dong X; Sweitzer SM; Raja SN; Guan Y
Pain; 2013 Nov; 154(11):2477-2486. PubMed ID: 23880055
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats.
Shannon HE; Lutz EA
Neuropharmacology; 2002 Feb; 42(2):253-61. PubMed ID: 11804622
[TBL] [Abstract][Full Text] [Related]
12. Relative contributions of peripheral versus supraspinal or spinal opioid receptors to the antinociception of systemic opioids.
Khalefa BI; Shaqura M; Al-Khrasani M; Fürst S; Mousa SA; Schäfer M
Eur J Pain; 2012 May; 16(5):690-705. PubMed ID: 22337491
[TBL] [Abstract][Full Text] [Related]
13. Co-administration of δ- and μ-opioid receptor agonists promotes peripheral opioid receptor function.
Schramm CL; Honda CN
Pain; 2010 Dec; 151(3):763-770. PubMed ID: 20970925
[TBL] [Abstract][Full Text] [Related]
14. Antihyperalgesic effects of delta opioid agonists in a rat model of chronic inflammation.
Fraser GL; Gaudreau GA; Clarke PB; Ménard DP; Perkins MN
Br J Pharmacol; 2000 Apr; 129(8):1668-72. PubMed ID: 10780972
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effect of intrathecal loperamide: role of mu-opioid receptor and calcium channels.
Kumar R; Reeta KH; Ray SB
Eur J Pharmacol; 2012 Dec; 696(1-3):77-82. PubMed ID: 23022331
[TBL] [Abstract][Full Text] [Related]
16. Analgesic properties of loperamide differ following systemic and local administration to rats after spinal nerve injury.
Chung C; Carteret AF; McKelvy AD; Ringkamp M; Yang F; Hartke TV; Dong X; Raja SN; Guan Y
Eur J Pain; 2012 Aug; 16(7):1021-32. PubMed ID: 22508374
[TBL] [Abstract][Full Text] [Related]
17. Central Nervous System Distribution of an Opioid Agonist Combination with Synergistic Activity.
Griffith JI; Kim M; Bruce DJ; Peterson CD; Kitto KF; Mohammad AS; Rathi S; Fairbanks CA; Wilcox GL; Elmquist WF
J Pharmacol Exp Ther; 2022 Jan; 380(1):34-46. PubMed ID: 34663676
[TBL] [Abstract][Full Text] [Related]
18. Relative contribution of peripheral versus central opioid receptors to antinociception.
Labuz D; Mousa SA; Schäfer M; Stein C; Machelska H
Brain Res; 2007 Jul; 1160():30-8. PubMed ID: 17599812
[TBL] [Abstract][Full Text] [Related]
19. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
20. Nociceptive sensitivity and opioid antinociception and antihyperalgesia in Freund's adjuvant-induced arthritic male and female rats.
Cook CD; Nickerson MD
J Pharmacol Exp Ther; 2005 Apr; 313(1):449-59. PubMed ID: 15608071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
